Glad to see this but I wish they would feel for once that we deserved to know what the deal is. What is it going to cost us?

RVXoldtimer, it would be nice to know those granular details but I really don't care what it is going to cost to produce -- we will be able to build-in a margin for ourselves no matter what. And only months after approval revenues coming through the door should be in the billions.  

At this stage our fate doesn't depend on establishing a fat margin.  It depends on getting revenues inside the door to stop the bleeding, stop the investor skepticism and then really go hardcore and fund bigger trials internally like BOM2 and BOM Renal without further shareholder dilution.  

JMHO